Delivery Order SPE2DB24D1007-SPE2DB25FBZLA
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,433.67 firm fixed-price delivery order is for the pharmaceutical product Otezla 30 mg tablet, 60 count. The contract has an ultimate completion date of January 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of Otezla 30 mg tablets. The $82,593.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of November 20, 2024. The award is not associated with any set-aside program. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for providing a broad...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) covers the delivery of Otezla 30mg tablets. The $36,882.62 firm fixed-price delivery order falls under a larger indefinite delivery contract (IDC) valued at $999,999,999 that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $31,783.40, is for the supply of Otezla 30 mg tablets. The contract is a delivery order with a firm fixed price and has a completion date of December 20, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Otezla 30 mg tablets. The $7,473.38 firm fixed-price delivery order has a completion date of May 1, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $39,001.06, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Otezla 30 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,341.67 firm fixed-price delivery order is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024. This award is a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Otezla 30 mg tablets. The contract, valued at $5,577.66, is a Firm Fixed Price Delivery Order that runs through November 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,913.28 for the supply of OTEZLA 30 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $8,219.64 firm fixed-price delivery order is for Otezla 30 mg tablets. The award has no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 15, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...